Stem-cell driven cancer: "Hands-off" regulation of cancer development

Cell Cycle

Volumn 8, Issue 9, 2009, Pages 1314-1318

  Vicente Dueñas, Carolina ^a   Pérez Caro, María ^a   Abollo Jiménez, Fernando ^a   Cobaleda, César ^a   Sánchez García, Isidro ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Cancer maintaining cells; Cancer stem cells; Cancer therapy; Oncogenes; Stem cells

Indexed keywords

ATAXIN 1; BCR ABL PROTEIN; GANCICLOVIR;

ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER MODEL; CANCER STEM CELL; CARCINOGENESIS; CHRONIC MYELOID LEUKEMIA; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; MOUSE; NONHUMAN; ONCOGENE; STEM CELL; TARGET CELL;

EID: 65949090730     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.9.8217     Document Type: Article

References (26)

1. Santos E, Tronick SR, Aaronson SA, Pulciani S, Barbacid M. T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes. Nature 1982; 298:343-7.
2. Lane MA, Sainten A, Cooper GM. Stage-specific transforming genes of human and mouse B- and T-lymphocyte neoplasms. Cell 1982; 28:873-80.
3. Parada LF, Tabin CJ, Shih C, Weinberg RA. Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature 1982; 297:474-8.
4. Goldfarb M, Shimizu K, Perucho M, Wigler M. Isolation and preliminary characterization of a human transforming gene from T24 bladder carcinoma cells. Nature 1982; 296:404-9.
5. Chin L, Tam A, Pomerantz J, Wong M, Holash J, Bardeesy N, et al. Essential role for oncogenic Ras in tumour maintenance. Nature 1999; 400:468-72.
6. Huettner CS, Zhang P, Van Etten RA, Tenen DG. Reversibility of acute B-cell leukaemia induced by BCR-ABL1. Nat Genet 2000; 24:57-60.
7. Boxer RB, Jang JW, Sintasath L, Chodosh LA. Lack of sustained regression of c-MYC-induced mammary adenocarcinomas following brief or prolonged MYC inactivation. Cancer Cell 2004; 6:577-86.
8. Weinstein IB. Cancer. Addiction to oncogenes - the Achilles heal of cancer. Science 2002; 297:63-4.
9. Cobaleda C, Busslinger M. Developmental plasticity of lymphocytes. Curr Opin Immunol 2008; 20:139-48.
10. Cohnheim J. Ueber entzundung und eiterung. Path Anat Physiol Klin Med 1867; 40:1-79.
11. Virchow R. Editorial. Virchows Arch Pathol Anat Physiol Med 1855.
12. Graham SM, Jorgensen HG, Allan E, Pearson C, Alcorn MJ, Richmond L, et al. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood 2002; 99:319-25.
13. Jorgensen HG, Holyoake T. Characterization of cancer stem cells in chronic myeloid leukaemia. Biochem Soc Trans 2007; 35:1347-51.
14. Reya T, Morrison SJ, Clarke MF and Weissman IL. Stem cells, cancer and cancer stem cells. Nature 2001; 414:105-11.
15. Perez-Caro M and Sanchez-Garcia I. Killing time for cancer stem cells (CSC): discovery and development of selective CSC inhibitors. Curr Med Chem 2006; 13:1719-25.
16. Dalerba P, Cho RW and Clarke MF. Cancer stem cells: models and concepts. Annu Rev Med 2007; 58:267-84.
17. Pérez-Caro M, Cobaleda C, González-Herrero I, Vicente-Dueñas C, Bermejo-Rodríguez C, Sánchez-Beato M, et al. Cancer induction by restriction of oncogene expression to the stem cell compartment. EMBO J 2009; 28:8-20.
18. Koeffler HP and Golde DW. Chronic myelogenous leukemia - new concepts (first of two parts). N Engl J Med 1981; 304:1201-9.
19. Melo JV and Barnes DJ. Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat Rev Cancer 2007; 7:441-53.
20. Rossi DJ, Bryder D, Zahn JM, Ahlenius H, Sonu R, Wagers AJ, et al. Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci USA 2005; 102:9194-9.
21. Etzioni R, Urban N, Ramsey S, McIntosh M, Schwartz S, Reid B, et al. The case for early detection. Nat Rev Cancer 2003; 3:243-52.
22. Chabner BA and Roberts TG Jr. Timeline: Chemotherapy and the war on cancer. Nat Rev Cancer 2005; 5:65-72.
23. Huff CA, Matsui W, Smith BD and Jones RJ. The paradox of response and survival in cancer therapeutics. Blood 2006; 107:431-4.
24. Sánchez-García I. The crossroads of oncogenesis and metastasis. N Engl J Med 2009; 360:297-9.
25. Sánchez-García I, Vicente-Dueñas C, Cobaleda C. The theoretical basis of cancer-stem-cell-based therapeutics of cancer: can it be put into practice? Bioessays 2007; 29:1269-80.
26. Cobaleda C, Gutierrez-Cianca N, Perez-Losada J, Flores T, Garcia-Sanz R, Gonzalez M, et al. A primitive hematopoietic cell is the target for the leukemic transformation in human philadelphia-positive acute lymphoblastic leukemia. Blood 2000; 95:1007-13.